Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1999, p. 1584-1586, Vol. 37, No. 5
Escuela de
Enfermería,1 and
Microbiología
Received 8 June 1998/Returned for modification 20 July
1998/Accepted 16 January 1999
We studied 70 intensive care unit patients to determine the
incidence of nosocomial candiduria associated with indwelling urinary
catheters and to assess microbiological characteristics of the yeasts.
The yeasts were isolated, 13 of 17 in urine cultures and 4 of 17 in
blood cultures, and colonization had occurred 3 days after the
insertion of indwelling urinary catheters. For four strains the MICs of
the antifungal drugs were high.
Nosocomial fungal infections are
important causes of morbidity and mortality in patients admitted to
intensive care units (ICU).
Urinary catheters have been held responsible as a cause of 80% of
hospital urinary tract infections (UTI) (20). The
surveillance data from the U.S. National Nosocomial Infections
Surveillance system reported Candida albicans to be the
fourth most common pathogen in UTI (11).
Candida spp. make up part of the human biota, and
their qualitative isolation from urine cultures alone does not
reveal evidence of infection (6). The concept of
hospital candiduria would involve the development of UTI caused
by Candida spp., with a culture of The objective of this investigation was to check prospectively the
incidence of urinary catheter-associated hospital candiduria and to
evaluate the microbiological characteristics of the yeasts isolated
from ICU patients with indwelling urinary catheters.
From June 1995 through January 1996 all adult patients admitted
consecutively to the ICU of the Hospital São Paulo and undergoing urethral catheterization with negative urine and blood cultures at the
time of admission were investigated. All patients who presented positive yeast urine cultures 72 h after the insertion of a
urinary catheter were considered in this investigation. Patients who
did not present positive yeast urine cultures during their ICU
stays were considered the control group. Patients with previous
histories of repeated urinary infections, with indwelling urinary
catheters of uncertain origin and uncertain date of insertion, and
those with positive fungal urine cultures during the first 24 h of
catheterization were excluded (7, 15).
Urine, blood, and vaginal secretion samples were collected
systematically upon admission and after each 72-h interval
during the ICU stay of the patient. Final samples were collected
48 h after ICU discharge.
Blood cultures were incubated in the semiautomatized Bactec
system (Becton Dickinson). The processing of blood, urine, and vaginal
secretion specimens and the identification of isolated yeasts
were carried out according to standard methods (18). Yeast profiles of susceptibility to antifungal agents were
assessed by the means of broth microdilution (10). Results
of doubtful readings or results with samples for which there were very
high MICs were confirmed by the macrodilution technique (9).
In our study, 70 adult patients were evaluated. The investigation
revealed a median of 70 years of age for patients with urine cultures
positive for yeasts; the calculated mean was 65 years of age, which is
in agreement with the work of Hamory and Wenzel (7).
The presence of yeasts was observed in 18.6% of urine
specimens from patients with indwelling urinary catheters (Table
1). Values between 11 and 25.7% were
reported by other authors (7, 15, 16). A total of 8 of 26 women (30.8%) presented yeast isolation, whereas in the 44 male
subjects the percentage was 11.4% (relative risk [RR] = 1.95;
confidence level [CL] [95%] = 1.1 to 3.46; P = 0.04), in accordance with the work of Gubbins et al.
(6). We found that five of the eight patients with initial positive vaginal secretions later showed the presence of the same yeast
species in their urine. The yeast ascent from the female genitourinary
tract to the urinary tract may be influenced by anatomofunctional
factors related to that sex and explains the greater incidence of
candiduria in women (5, 8).
The candidemia incidence of 5.7% found in our investigation does not
differ from that reported by other authors (2, 21). C. albicans, Candida parapsilosis, Candida
tropicalis, and Candida famata were isolated from
each patient. According to some researchers, candiduria occurs mainly
through a descending route (6). Nevertheless, the four
patients who presented candidemia did not have positive urine cultures
during a period of up to eight follow-up days.
Several researchers have emphasized the role of species other
than C. albicans as emergent pathogens in UTI (6, 12,
14). We isolated C. albicans (46.15%) most often,
followed by Candida glabrata (30.77%) and Candida
krusei (7.7%), from urine specimens (Table
2), which is in agreement with data
reported by other authors (3, 5, 18). The presence of
organisms from the genus Trichosporon in the urinary tract
has been scarcely reported in the literature (1, 19). It is
important to stress the isolation of Trichosporon inkin
(7.7%) in the urine of a 48-year-old male patient with multiple
injuries and Trichosporon ovoides (7.7%) in the urine
culture of a 68-year-old diabetic woman during the aneurysmectomy
postoperative period.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Microbiological Characteristics of Yeasts Isolated
from Urinary Tracts of Intensive Care Unit Patients Undergoing
Urinary Catheterization
Micología,
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
105
CFU/ml on a specimen collected at least 72 h after hospital
admission and a previous Candida spp.-negative culture
(7, 16). Nevertheless, the Centers for Disease
Control and Prevention offered a clear definition of bacterial
UTI, but the subject remains controversial as far as yeasts are
concerned (4).
TABLE 1.
Distribution of urine culture results according to sex
of patients who underwent urinary catheterization and were
admitted to the Hospital São Paulo ICU
TABLE 2.
Distribution of isolated yeast species in urine specimens
from 17 patients admitted to the Hospital São Paulo ICU
The specific identification of yeasts provides important help in the
choice of treatment, because C. glabrata and C. krusei are naturally resistant to fluconazole (13, 17).
From blood culture specimens one C. albicans strain for
which the fluconazole MIC was 64 µg/ml was isolated; from three urine
samples we identified one C. krusei strain for which the
fluconazole MIC was 64 µg/ml and two Trichosporon isolates
for which MICs of all tested drugs were high (Table
3).
|
The duration of catheterization is an important risk factor (20). Time intervals of 6, 7, or even 12 days have been reported by different authors for the identification of yeasts after the insertion of urinary catheters (5, 6). Our findings show that 9 of 13 patients undergoing catheterization and with positive urine cultures presented yeasts in their urine 72 h after the insertion of urinary catheters.
Urinary catheterization may cause candiduria, with the absence or presence of the disease suggesting that colony counts may reflect catheter colonization (6). Nevertheless, high counts of CFU/ml, obtained from urinary catheterized patients, would represent the amount of yeasts in the bladder and not necessarily catheter colonization (5). In our investigation we found that initial urine cultures with values lower than 20,000 CFU/ml (four patients) became negative without medical treatment. On the other hand, patients with isolation values higher than 20,000 CFU/ml received antifungal therapy. We should stress that the drug was administered without previous knowledge of the results of the mycological examination.
The natural history of urinary tract colonization or infection in
patients with indwelling urinary catheters has not been well defined
yet (5, 6). According to our findings, which are partially
in agreement with data reported in the literature, surveillance urine
cultures should be carried out in patients who present risk factors
such as previous antibiotic therapy, Foley catheterization, or
immunocompromised state or who are female ICU patients. If a yeast
count of
20,000 CFU/ml is obtained, a new urine sample should be
collected in the following 72 h, in order to evaluate the therapy conduct.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Escuela de Enfermería, Facultad de Medicina, Universidad de Chile, Condell 303, Providencia, Santiago, Chile. Phone: 56-2-2047848, ext. 15. Fax: 56-2-2047848, ext. 42. E-mail: nfebre{at}machi.med.uchile.cl.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Blancard, A., F. Gouin, S. Dunan, and M. Quilice. 1995. Infection urinaire à Trichosporon inkin. Med. Mal. Infect. 25:605-614. |
| 2. | Fraser, V. J., M. Jones, J. Dunkel, S. Storfer, G. Medoff, and C. W. Dunagan. 1992. Candidemia in tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin. Infect. Dis. 15:414-421[Medline]. |
| 3. | Frye, K. R., J. M. Donovan, and G. W. Drach. 1988. Torulopsis glabrata urinary infections: a review. J. Urol. 139:1245-1249[Medline]. |
| 4. | Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infection, Am. J. Infect. Control 16:1-28. |
| 5. | Goldberg, P. K., P. J. Kozzin, G. J. Wise, N. Nouri, and R. B. Brooks. 1978. Frequency and significance of candiduria. JAMA 24:582-584. |
| 6. | Gubbins, P. O., S. C. Piscitelli, and L. H. Danziger. 1993. Candida urinary tract infections: a comprehensive review of their diagnosis and management. Pharmacotherapy 13:110-127[Medline]. |
| 7. | Hamory, B. H., and R. P. Wenzel. 1978. Hospital-associated candiduria: predisposing factors and review of the literature. J. Urol. 120:444-448[Medline]. |
| 8. | Maffei, C. M. L. 1985. Amostras de Candida albicans isoladas de gestantes: factores de virulencia, sensibilidade antifúngica, tipagem fenotípica e genotípica. Ph.D. thesis. Universidade Federal de São Paulo, São Paulo, Brazil. |
| 9. | National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeast. Proposed standard M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. |
| 10. | National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeast. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 11. | National Nosocomial Infections Surveillance System. 1996. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996. Am. J. Infect. Control 24:380-388[Medline]. |
| 12. | O'Connell, C. J., and G. J. Harder. 1985. Thrush of urinary bladder due to Candida guilliermondii. J. Med. 73:1685-1686. |
| 13. | Odds, F. C. 1993. Resistance of yeast to azole-derivate antifungals. J. Antimicrob. Chemother. 31:46-71. |
| 14. | Pfaller, M., and R. Wenzel. 1992. Impact of the changing epidemiology of fungal infections in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 11:287-291[Medline]. |
| 15. | Platt, R., B. F. Polk, B. Murdock, and B. Rosner. 1982. Mortality associated with nosocomial urinary-tract infection. N. Engl. J. Med. 11:637-642. |
| 16. | Platt, R., B. F. Polk, B. Murdock, and B. Rosner. 1983. Reduction of mortality associated with nosocomial urinary-tract infection. Lancet i:893-897. |
| 17. | Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8[Medline]. |
| 18. | Richardson, M. D., and D. W. Warnock. 1993. Fungal infection. Diagnosis and management, p. 103-124. In M. D. Richardson, and D. W. Warnock (ed.), Deep candidosis. Blackwell Scientific Publications, Oxford, England. |
| 19. | Stone, J., and R. Manasse. 1989. Pseudoepidemic of urinary tract infections due to T. beigelli. Infect. Control Hosp. Epidemiol. 10:312-315[Medline]. |
| 20. | Wenzel, R. P. 1993. Prevention and control of nosocomial infections, 2nd ed. Williams, New York, N.Y. |
| 21. | Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149:2349-2353. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»